Home
/
Outset Medical, Inc.
/
Financials
/
Quarterly
Outset Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Outset Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$29.43M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$31.42M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$29.75M
May 8, 2025
Q3
2025
Sep 30, 2024
$28.67M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$27.39M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$28.17M
May 8, 2025
Q3
2024
Sep 30, 2023
$30.36M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$36.04M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$33.47M
May 9, 2024
Q3
2023
Sep 30, 2022
$27.76M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$25.06M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$30.55M
May 4, 2023
Q3
2022
Sep 30, 2021
$26.32M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$25.22M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$22.92M
May 5, 2022
Q3
2021
Sep 30, 2020
$13.76M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$11.74M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$7.19M
May 6, 2021
Q3
2020
Sep 30, 2019
$2.63M
Nov 12, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.84M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($18.54M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($18.54M)
Nov 10, 2025
Q2
2025
Mar 31, 2025
($25.78M)
Aug 7, 2025
Q3
2025
Mar 31, 2025
($25.78M)
Nov 10, 2025
Q1
2025
Mar 31, 2025
($25.78M)
May 8, 2025
Q3
2025
Sep 30, 2024
($27.94M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($34.45M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($34.45M)
Aug 7, 2025
Q2
2025
Mar 31, 2024
($39.94M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($39.94M)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($39.94M)
May 8, 2025
Q3
2024
Sep 30, 2023
($46.18M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($44.05M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($44.05M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($43.97M)
May 9, 2024
Q2
2024
Mar 31, 2023
($43.97M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($43.97M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($40.78M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
($43.84M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($15.81M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($16.87M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($16.40M)
May 8, 2025
Q3
2025
Sep 30, 2024
($23.84M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($30.76M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($36.91M)
May 8, 2025
Q3
2024
Sep 30, 2023
($45.45M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($43.48M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($43.49M)
May 9, 2024
Q3
2023
Sep 30, 2022
($41.00M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($43.72M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($36.48M)
May 4, 2023
Q3
2022
Sep 30, 2021
($30.14M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($29.91M)
Aug 2, 2022
Q1
2022
Mar 31, 2021
($29.68M)
May 5, 2022
Q3
2021
Sep 30, 2020
($40.73M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($24.91M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($20.21M)
May 6, 2021
Q3
2020
Sep 30, 2019
($18.45M)
Nov 12, 2020